These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33996168)

  • 21. In vitro characterisation of SARS-CoV-2 and susceptibility of domestic ferrets (Mustela putorius furo).
    Marsh GA; McAuley AJ; Brown S; Pharo EA; Crameri S; Au GG; Baker ML; Barr JA; Bergfeld J; Bruce MP; Burkett K; Durr PA; Holmes C; Izzard L; Layton R; Lowther S; Neave MJ; Poole T; Riddell SJ; Rowe B; Soldani E; Stevens V; Suen WW; Sundaramoorthy V; Tachedjian M; Todd S; Trinidad L; Williams SM; Druce JD; Drew TW; Vasan SS
    Transbound Emerg Dis; 2022 Mar; 69(2):297-307. PubMed ID: 33400387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
    Li Y; Wang H; Tang X; Fang S; Ma D; Du C; Wang Y; Pan H; Yao W; Zhang R; Zou X; Zheng J; Xu L; Farzan M; Zhong G
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic.
    Rosa RB; Dantas WM; do Nascimento JCF; da Silva MV; de Oliveira RN; Pena LJ
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33673614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects.
    Wang S; Li L; Yan F; Gao Y; Yang S; Xia X
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of animal models for COVID-19.
    Qi F; Qin C
    Animal Model Exp Med; 2022 Oct; 5(5):401-409. PubMed ID: 36301011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes.
    Choudhary S; Kanevsky I; Tomlinson L
    Vet Pathol; 2022 Jul; 59(4):516-527. PubMed ID: 35451341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
    Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
    Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review.
    Salajegheh Tazerji S; Magalhães Duarte P; Rahimi P; Shahabinejad F; Dhakal S; Singh Malik Y; Shehata AA; Lama J; Klein J; Safdar M; Rahman MT; Filipiak KJ; Rodríguez-Morales AJ; Sobur MA; Kabir F; Vazir B; Mboera L; Caporale M; Islam MS; Amuasi JH; Gharieb R; Roncada P; Musaad S; Tilocca B; Koohi MK; Taghipour A; Sait A; Subbaram K; Jahandideh A; Mortazavi P; Abedini MA; Hokey DA; Hogan U; Shaheen MNF; Elaswad A; Elhaig MM; Fawzy M
    J Transl Med; 2020 Sep; 18(1):358. PubMed ID: 32957995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
    Abdelaziz MO; Raftery MJ; Weihs J; Bielawski O; Edel R; Köppke J; Vladimirova D; Adler JM; Firsching T; Voß A; Gruber AD; Hummel LV; Fernandez Munoz I; Müller-Marquardt F; Willimsky G; Elleboudy NS; Trimpert J; Schönrich G
    Front Immunol; 2023; 14():1166765. PubMed ID: 37520530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.